Fortress Biotech Inc [FBIO] stock is trading at $2.18, up 10.10%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The FBIO shares have gain 26.01% over the last week, with a monthly amount glided 3.81%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 22, February 2024, Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy. In a post published today on Yahoo Finance, -In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell’s Genetic Absence Epilepsy Rat from Strasbourg (“GAERS”) model of absence epilepsy-.
From an analyst’s perspective:
Fortress Biotech Inc [NASDAQ: FBIO] stock has seen the most recent analyst activity on August 04, 2022, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $6. Previously, The Benchmark Company started tracking the stock with Buy rating on October 02, 2020, and set its price target to $9. On December 18, 2019, B. Riley FBR initiated with a Buy rating and assigned a price target of $9 on the stock. B. Riley FBR Inc. started tracking the stock assigning a Buy rating and suggested a price target of $10 on February 28, 2018. Rodman & Renshaw initiated its recommendation with a Buy and recommended $11 as its price target on July 11, 2017. In a note dated October 03, 2016, ROTH Capital initiated an Buy rating and provided a target price of $9 on this stock.
Fortress Biotech Inc [FBIO] stock has fluctuated between $1.24 and $12.75 over the past year. Fortress Biotech Inc [NASDAQ: FBIO] shares were valued at $2.18 at the most recent close of the market.
Analyzing the FBIO fundamentals
Fortress Biotech Inc [NASDAQ:FBIO] reported sales of 80.97M for the trailing twelve months, which represents a growth of 110.26%. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -2.18%, Pretax Profit Margin comes in at -2.25%, and Net Profit Margin reading is -1.35%. To continue investigating profitability, this company’s Return on Assets is posted at -0.73, Equity is -3.81 and Total Capital is -3.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 4.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.0100 points at the first support level, and at 1.8300 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.3200, and for the 2nd resistance point, it is at 2.4500.
Fortress Biotech Inc [FBIO] reported earnings per share of -$0.94 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$3.21/share, meaning a difference of $2.27 and a surprise factor of 70.70%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$3.6 per share as compared to estimates of -$3.41 per share, a difference of -$0.19 representing a surprise of -5.60%.
Ratios To Look Out For
For context, Fortress Biotech Inc’s Current Ratio is 1.00. As well, the Quick Ratio is 0.89, while the Cash Ratio is 0.74. Considering the valuation of this stock, the price to sales ratio is 0.49, the price to book ratio is 0.08.
Transactions by insiders
Recent insider trading involved ROSENWALD LINDSAY A MD, President, CEO & Chairman, that happened on Jan 05 when 50000.0 shares were purchased. President, CEO & Chairman, ROSENWALD LINDSAY A MD completed a deal on Nov 14 to buy 1.57 million shares. Meanwhile, WEISS MICHAEL S bought 0.15 million shares on Nov 14.
